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A specialized subset of epithelial cells in the thymus ‘‘promiscuously’’ transcribes thousands of
peripheral genes to ensure that developing T cells can test their antigen receptors for dangerous
autoreactivity. New findings by Takaba et al. indicate that the transcription factor Fezf2 acts inde-
pendently of Aire in thymic epithelial cells to generate ‘‘genetic noise’’ for immunological tolerance.During T cell differentiation in the thymus,
every T cell is equipped with a unique
antigen receptor generated through so-
matic rearrangements. Whereas this vast
T cell receptor repertoire confers protec-
tion against a universe of constantly
evolving pathogens, the random nature
of the rearrangement process inevitably
leads to the emergence of potentially
dangerous T cells that recognize the
body’s own structures. Prior to being
released into the blood circulation, imma-
ture T cells must therefore ‘‘test’’ their
antigen specificity on ligands within the
thymic microenvironment and will un-
dergo negative selection against autor-
eactivity. The scope of self-antigens that
are visible to T cells for central tolerance
is substantially broadened through the
constitutive expression of a plethora of
tissue restricted antigens (TRAs) by med-
ullary thymic epithelial cells (mTECs)
(Derbinski et al., 2001; Klein et al., 2014).
This phenomenon is referred to as ‘‘pro-
miscuous gene expression,’’ and it has
evolved to facilitate T cell tolerance to-
ward self-antigens that would otherwise
be temporally or spatially secluded from
the immune system. In this issue of Cell,
Takaba et al. (2015) identify the transcrip-
tion factor Fezf2 as a key driver of promis-
cuous gene expression in mTECs, essen-
tial to prevent spontaneous autoimmunity
against multiple tissues (Takaba et al.,
2015).
Tightly controlled expression of cell-
type-specific genetic programs is indis-
pensable for tissue identity and homeo-
stasis, and multiple layers of control act
in concert to prevent ectopic gene
expression. How do mTECs deliberately
violate these rules in order to generate
‘‘beneficial genetic noise’’? A break-
through in the field emerged from studies794 Cell 163, November 5, 2015 ª2015 Elsevon the autoimmune polyendocrine syn-
drome (APS), a monogenically inherited
human autoimmune disease resulting
from mutations in the autoimmune regu-
lator (Aire) gene. In mice, Aire was found
to be essential for ‘‘ectopic’’ TRA ex-
pression in mTECs, and knockout of
Aire recapitulated several aspects of
APS (Anderson et al., 2002). Strikingly,
however, it turned out that promiscuous
gene expression was not fully abolished
in the absence of Aire (Derbinski et al.,
2005), suggesting the existence of addi-
tional transcriptional regulators. Still,
most research in the field focused on
deciphering the molecular workings of
Aire (Mathis and Benoist, 2009; Peterson
et al., 2008), while largely ignoring how
Aire-independent promiscuous gene ex-
pression is regulated. Here, Takaba et al.
(2015) hypothesize that any Aire-indepen-
dent additional regulators of promiscuous
gene expression should be differentially
expressed between mTECs and their
nearest neighbor, the cortical thymic
epithelial cells (cTECs), who share a com-
mon precursor with mTECs but do not ex-
press TRAs. Among the genes that were
differentially expressed in mTECs versus
cTECs, they find the transcriptional re-
gulator Fezf2 (forebrain expressed zinc
finger 2) to be expressed in mTECs, but
not in other thymic stromal cell types. Pre-
vious work has implicated Fezf2 in corti-
cospinal motor neuron differentiation,
and Fezf2-deficient mice do not survive
beyond weaning, explaining why a poten-
tial role of Fezf2 in the immune system
may have gone unnoticed. By comparing
gene expression profiles, Takaba et al.
(2015) demonstrate that numerous TRA
transcripts are downregulated in Fezf2-
deficient mTECs. Importantly, the major-
ity of these Fezf2-dependent TRAs areier Inc.not affected in Aire-deficient mTECs,
and most Aire-dependent TRAs remain
expressed in the absence of Fezf2,
strongly supporting an Aire-independent
and non-redundant role of Fezf2 in the
promotion of promiscuous gene expres-
sion. Along these lines, the authors go
on to show that Fezf2 deficiency in thymic
epithelium elicits a spectrum of autoim-
mune manifestations that is partly distinct
from those seen in Aire-deficient mice.
Remarkably, several aspects of Fezf2’s
role in the thymus seem to follow a funda-
mentally different biological and mecha-
nistic logic as compared to what is known
about Aire (Figure 1). First, Aire’s function
as a ‘‘transcriptional randomizer’’ is likely
to have evolved simultaneous to, and
as a consequence of, the emergence
of adaptive T-cell-mediated immunity in
jawed vertebrates some 500 million years
ago (Saltis et al., 2008). By contrast,
Fezf2’s evolutionary conserved primary
function seems to be that of a master
regulator of cell fate specification in corti-
cospinal motor neurons. Thus, Aire ap-
pears to be a genuine ‘‘tolerance gene,’’
whereas Fezf2 instead might exemplify
the evolutionary co-optation of a neuronal
gene in a distinct cellular and functional
context. Second, Aire lacks a DNA-bind-
ing domain and seems to seek out its tar-
gets through binding inactive chromatin
marks prior to recruiting factors that facil-
itate ‘‘illegitimate’’ transcription by gener-
ating double-strand breaks, fostering
mRNA processing, and releasing stalled
RNA Polymerase (Mathis and Benoist,
2009; Peterson et al., 2008). By contrast,
Fezf2 is a ‘‘bona fide’’ transcription factor
that directly binds to target DNA. In
neuronal progenitors, Fezf2 binds in the
vicinity of the transcriptional start site of
more than 10,000 genes (Lodato et al.,
Figure 1. Fezf2 and Aire Promote Promiscuous Gene Expression through Distinct Pathways
Takaba et al. (2015) show that Fezf2 is induced downstream of lymphotoxin b receptor (LTbR) stimulation
in mTECs and generates ‘‘transcriptional noise’’ by directly binding to its target genes. By contrast,
previous work has indicated that Aire is activated by RANK/CD40 signaling. Aire binds to inactive chro-
matin marks (unmethylated H3K4) in the vicinity of tissue restricted antigen (TRA) genes and indirectly
promotes promiscuous gene expression through recruitment of factors that promote opening of chro-
matin, release of stalled RNA polymerase, and facilitation of mRNA maturation. Fezf2- and Aire-induced
TRAs appear to be largely non-overlapping, resulting in a non-redundant and complementary role of both
factors in central T cell tolerance.2014), which has obvious implications for
the spectrum of genes that might be
controlled by Fezf2 in mTECs. Finally,
whereas Aire expression in mTECs is
regulated by the TNF superfamily mem-
bers RANK and CD40, Takaba et al.
(2015) show that the expression of Fezf2
critically depends upon the lymphotoxin
(LT) b signaling axis.
Taken together, the work by Takaba
et al. (2015) represents a major step for-
ward in our understanding of how promis-
cuous gene expression in mTECs isbrought about and how it safeguards
against autoimmunity. At the same time,
these exciting new insights raise a num-
ber of questions: do the altered 3D organi-
zation of the thymic medulla and subtle
alterations in the ratio of mTEC subsets
in Fezf2–/– mice contribute to faulty T cell
selection independent of Fezf2’s role in
promiscuous gene expression? Given
the perplexing observation that individual
mTECs only express a subset of Aire-
dependent TRAs, does the same apply
to Fezf2-dependent transcripts? DoesCell 163,Fezf2 similarly promote promiscuous
gene expression in the human thymus,
and if so, are mutations or allelic variants
of Fezf2 associated with human autoim-
mune diseases? And finally, does the
complementary action of Aire and Fezf2
account for the full extent of promiscuous
gene expression in mTECs, or are as-yet-
unknown, additional, and independent
factors involved?REFERENCES
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